Oncolytics Biotech

Oncolytics Biotech

ONCY· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -4.4% in FY2025

Jared Kelly is the CEO of Oncolytics Biotech and was paid $2.1M in FY2025 (Dec).

Pay$100 in the stock at the end of FY24 → $96
CEO pay is from each Oncolytics Biotech proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Jared KellyFY2025
  2. 2Thomas C. HeinemanFY2025
  3. 3Kirk LookFY2025
  4. 4Wayne PisanoFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Oncolytics Biotech paid its 4 named executives $4.9M in total in FY2025 (Dec). CEO Jared Kelly was paid $2.1M of that.

Name
Jared KellyChief Executive OfficerNot disclosed
Thomas C. HeinemanChief Medical Officer
Kirk LookChief Financial Officer
Wayne PisanoFormer Interim CEO

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Oncolytics Biotech. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings2

See all
Proxy statementDEF 14AOct 6, 2026FY2025
Annual report10-KMar 30, 2026FY2025
For the press:Download CSVDownload PNGHow to use our data